Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

China flag China · Delayed Price · Currency is CNY
7.43
+0.01 (0.13%)
Feb 27, 2026, 3:04 PM CST
Market Cap3.74B +27.2%
Revenue (ttm)1.05B +8.9%
Net Income172.02M -23.9%
EPS0.34 -23.9%
Shares Out503.20M
PE Ratio21.73
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,209,486
Average Volume30,765,081
Open7.56
Previous Close7.43
Day's Range7.32 - 7.56
52-Week Range5.21 - 8.60
Beta0.29
RSI56.97
Earnings DateApr 28, 2026

About SHE:002412

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China. [Read more]

Sector Healthcare
Founded 1998
Employees 1,675
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002412
Full Company Profile

Financial Performance

In 2024, SHE:002412's revenue was 1.00 billion, an increase of 5.12% compared to the previous year's 955.53 million. Earnings were 220.24 million, an increase of 7.43%.

Financial Statements